Viemed Healthcare Q2 revenue rises on ventilator patient growth

Viemed Healthcare

03/08/2026 22:23

Overview
US home healthcare provider's Q2 revenue rose 24% yr/yr to a record high
Adjusted EBITDA for Q2 fell 4% yr/yr due to prior-year non-recurring gain
Company repurchased and cancelled 530,802 for $5.1 mln during Q2

Outlook
Viemed raises 2026 net revenue guidance to $314 mln-$320 mln from $312 mln-$320 mln
Company revises 2026 Adjusted EBITDA outlook to $64 mln-$68 mln from $65 mln-$69 mln
Net capital expenditures for 2026 now seen at 8.5%-10.0% of net revenue, down from 9.0%-10.5%

Result Drivers
VENTILATOR PATIENT GROWTH - Co said record ventilator patient census and strong setup activity contributed to revenue growth
PAP AND RESUPPLY EXPANSION - Co cited record PAP therapy volume and continued expansion in resupply and maternal health as supporting growth
DIVERSIFIED PLATFORM - CEO said results reflect a more diversified business with multiple growth engines and ongoing investments in technology and patient care

Company press release: ID:nACS7qYBpa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Meet
$78.10 mln
$78.10 mln (2 Analysts)
Q2 EPS
 
$0.07
 
Q2 Net Income
 
$2.90 mln
 
Q2 Gross Profit
 
$45.05 mln
 
Q2 Income from Operations
 
$4.46 mln
 
Q2 Pretax Profit
 
$4.05 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Viemed Healthcare Inc is $13.00, about 11.4% above its July 31 closing price of $11.67
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 19 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)